Delivery Order SPE2DB20D1100-SPE2DB24FC0L0

Award Date 5/31/24
Potential Completion Date 6/3/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,703.00 firm fixed-price delivery order contract is for the supply of NAFTIFINE HCL 1% CREAM 90GM. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,036.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NAFTIFINE HCL 1% CREAM 60GM. The contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $1,873.54 for the supply of 4556611118 - Naftifine HCL 1% Cream 60GM. The contract has an ultimate completion date of March 21, 2022 and was awarded on March 18, 2022 under a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NAFTIFINE HCL 2% CREAM 45GM, a pharmaceutical product, with a ceiling value of $5,724.04. The contract is a firm fixed price delivery order with an ultimate completion date of October 13, 2023. The contract was not designated as a set-aside. AmerisourceBergen...
The provided information details a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,389.08 firm fixed-price delivery order contract is for the provision of NAFTIFINE HCL 1% cream, a pharmaceutical product. This contract appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDYQT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,725.26 firm fixed-price delivery order is for the supply of NAFTIFINE HCL 1% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order valued at $1,385.12 for the supply of 4565752999 - Naftifine HCL 2% Cream 45GM. The contract was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued at up to $999,999,999 and $750,000 respectively,...
This federal contract award is for the delivery of NAFTIFINE HCL 2% CREAM 60GM to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $2,564.44 and a performance period through March 11, 2024. Amerisourcebergen Drug Corp also holds an...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NAFTIFINE HCL 2% cream in 45 gram tubes, with a total ceiling value of $1,149.90 and a completion date of December 29, 2023. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $4,737.94 for the supply of NAFTIFINE HCL 1% CREAM 60GM. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2023. The contract type is Firm Fixed Price, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC0L0
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Naftifine HCL 2% cream in 60-gram units. The $2,697.07 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on May 31, 2024, with a completion date of June 3, 2024. This order is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 8/30/24, 6:39 PM